Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Hevaxin is a novel, recombinant vaccine approved by the Drug Controller General of India (DCGI) for active immunization against the Hepatitis E virus (HEV) in adults aged 18 to 65.
Hevaxin is a novel, recombinant vaccine approved by the Drug Controller General of India (DCGI) for active immunization against the Hepatitis E virus (HEV) in adults aged 18 to 65.